FK 3311; 116686-15-8; FK-3311; N-[4-acetyl-2-(2,4-difluorophenoxy)phenyl]methanesulfonamide; COX-2 Inhibitor V, FK3311; FK3311;
A prostaglandin receptor antagonist potentially for the treatment of rheumatoid arthritis.
|Molecular Weight:||341.329826 g/mol|
This compound has been obtained by two different ways: 1) The oxidation of 4′-amino-3′-chloroacetophenone (I) with NaNO2 and HCl in water gives 3′-chloro-4-nitroacetophenone (II), which is condensed with 2,4-difluorophenol (III) by means of K2CO3 in xylene yielding 3′-(2,4-difluorophenyl)-4′-nitroacetophenone (IV). The reduction of (IV) with Fe and NH4Cl in ethanol affords the corresponding 4′-amino compound (V), which is finally treated with methanesulfonyl chloride and pyridine. 2) The reaction of 4′-aminoacetophenone (VI) with methanesulfonyl chloride as before gives the corresponding sulfonamide (VII), which is brominated with Br2 in acetic acid yielding N-(4-acetyl-3-bromophenyl)methanesulfonamide (VIII). Finally, this compound is condensed with 2,4-difluorophenol (III) by means of K2CO3 and CuCl as before.
Chem Pharm Bull 1992,40(9),2399
1 to 4 of 4
|METHODS TO TREAT INFECTIONS [US2014329777]||2014-04-22||2014-11-06|
|NOVEL NIMESULIDE COMPOSITIONS [US2012063996]||2011-07-28||2012-03-15|
|NANOPARTICULATE MELOXICAM FORMULATIONS [US2014141083]||2013-07-12||2014-05-22|
|Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same [US4866091]||1989-09-12|